L-dopa in postencephalitic parkinsonism.
D000368:Aged; D001264:Athetosis / Q000139:chemically induced; D002819:Chorea / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003702:Delusions / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy*; D010919:Placebos; D011605:Psychoses, Substance-Induced / Q000209:etiology
D010919:Placebos; D004295:Dihydroxyphenylalanine